3Lin P, Torres G, Tyring SK. Changing paradigms in dermatology: antivirals in dermatology. Clin Dermatol 2003;21(5) :426 - 446. 被引量：1
4Siemp AE, Kirschner RE. Keloids and scars;A review of keloids and scars,their pathogenesis, risk factors, and management [ J]. Current Opinion in Pediatrics,2006,1 8(4) :396-402. 被引量：1
5Robles DT, Moore E, Draznin, et al. Keloids: pathophysiology and management [ J ]. Dermatol Online,2007.13 ( 3 ) :9. 被引量：1
6Mameros AG, Non-is JE, Watanabe S, et al. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11 [ J]. J Invest Dermatol, 2004,122 ( 5 ) : 1126-1132. 被引量：1
7Maarouf M,Schleicher U, Sehmachtenberg A, et al. Radiotherapy in the management of keloids Clinical experience with electron beam irradiation and comparison with X-ray therapy [ J ]. Strahlenther Onkol, 2002, 178(6) :330-335. 被引量：1
8Bayat AB, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease and hypertro -phic scarring:transforming growth factor beta 1 common polymorphisms and plasma levels [ J ] . Plast Reconstr Surg, 2003,111 (2) :535-543. 被引量：1
